Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Manish Sahni, MD for Tirzepatide-Based Weight Loss at Centra Internal Medicine Centra Internal Medicine stands at the forefront of advanced obesity management, offering patients innovative, evidence-based treatment options such as tirzepatide
The medication comes from licensed 503A compounding pharmacies and is HSA/FSA eligible, making precision weight loss therapy accessible and affordable
Venancio-Brochi et al
1, the company said in a news release
US$ 27.87
US$ 29.54
US$ 27.15
US$ 21.91
US$ 20.91
